PX3 Sleep
Research
Preliminary PX3 Clinical Sleep Trial Results
PX3 is by definition a fully customized Mandibular Advancement Device (MAD) and is clinically validated to treat mild to moderate obstructive sleep apnea (OSA). Numerous studies on MADs and oral appliance therapy have demonstrated the effectiveness of treating mild to moderate OSA with such devices.
While CPAP therapy remains a top option for patients suffering from OSA, PX3 offers a viable alternative for those unable to tolerate CPAP or seeking non-surgical or non-pharmacological solutions.​ Before deciding on any treatment options, consult a qualified medical or dental professional.
43.52% decrease in apnea events
43.32% decrease in snoring
1.59% increase in blood oxygen levels
Supporting (MAD) studies
PX3 Performance Research
Physiological Effects of Wearing Athletic Mouth Pieces While Performing Various Exercises
Military Medicine, Volume 183, Issue suppl_1, March-April 2018, Pages 510–515,
Michael F Zupan, USAFA, BSC (Ret.), Dyana L Bullinger, MS, Brenda Buffington, EdD, Caroline Koch, BS, Samantha Parker, BS, Steve Fragleasso, BS, Taylor Fogg, Shay Rasmussen-Woerner, BS
Participants:
Twenty-five fully informed, non-smoking male and female subjects participated in this research study. The subject pool comprised non-smoking United States Air Force Academy (USAFA) cadets, USAFA civilian employees, and United States military members that were currently partaking in aerobic exercise for more than 30 min/d, at least three times per week.
13% increase in strength
9% increase in endurance
